New Research Study Supports Clinical Utility of Circulating Tumor Cell Count for Metastatic Breast Cancer ...Middle East

PR Newswire - News
First randomized clinical trial demonstrating that CTC count may help personalize treatment choices BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Nov. 9, 2020 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, today announced the publication of a research...

Read More Details
Finally We wish PressBee provided you with enough information of ( New Research Study Supports Clinical Utility of Circulating Tumor Cell Count for Metastatic Breast Cancer )

Apple Storegoogle play

Also on site :